HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Retinal degeneration 12 (rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis (LCA).

AbstractPURPOSE:
To report the phenotype and characterization of a new, naturally occurring mouse model of hereditary retinal degeneration (rd12).
METHODS:
The retinal phenotype of rd12 mice were studied using serial indirect ophthalmoscopy, fundus photography, electroretinography (ERG), genetic analysis including linkage studies and gene identification, immunohistochemistry, and biochemical analysis.
RESULTS:
Mice homozygous for the rd12 mutation showed small punctate white spots on fundus examination at 5 months of age. The retina in the rd12 homozygote had a normal appearance at the light microscopic level until 6 weeks of age when occasional voids appeared in the outer segments (OS) of the photoreceptor (PR) cells. The outer nuclear layer (ONL) appeared normal until 3 months of age though more obvious voids were detected in the OS. By 7 months of age, 6 to 8 layers of ONL remained in the mutant retina, and the OS were obviously shorter. The first sign of retinal degeneration was detected at the electron microscopic level around 3 weeks of age when occasional small lipid-like droplets were detected in the retinal pigment epithelium (RPE). By 3 months of age, much larger, lipid-like droplets accumulated in RPE cells accompanied by some OS degeneration. While the histology indicated a relatively slow retinal degeneration in the rd12 homozygous mutant mice, the rod ERG response was profoundly diminished even at 3 weeks of age. Genetic analysis showed that rd12 was an autosomal recessive mutation and mapped to mouse chromosome 3 closely linked to D3Mit19, a location known to be near the mouse Rpe65 gene. Sequence analysis showed that the mouse retinal degeneration is caused by a nonsense mutation in exon 3 of the Rpe65 gene, and the gene symbol for the rd12 mutation has been updated to Rpe65rd12 to reflect this. No RPE65 expression, 11-cis retinal, or rhodopsin could be detected in retinas from rd12 homozygotes, while retinyl esters were found to accumulate in the retinal pigment epithelium (RPE).
CONCLUSIONS:
Mutations in the retinal pigment epithelium gene encoding RPE65 cause an early onset autosomal recessive form of human retinitis pigmentosa, known as Leber congenital amaurosis (LCA), which results in blindness or severely impaired vision in children. A naturally arising mouse Rpe65 mutation provides a good model for studying the pathology of human RPE65 mutations and the effects of retinyl ester accumulation.
AuthorsJi-Jing Pang, Bo Chang, Norman L Hawes, Ronald E Hurd, Muriel T Davisson, Jie Li, Syed M Noorwez, Ritu Malhotra, J Hugh McDowell, Shalesh Kaushal, William W Hauswirth, Steven Nusinowitz, Debra A Thompson, John R Heckenlively
JournalMolecular vision (Mol Vis) Vol. 11 Pg. 152-62 (Feb 28 2005) ISSN: 1090-0535 [Electronic] United States
PMID15765048 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Carrier Proteins
  • Codon, Nonsense
  • Eye Proteins
  • Rhodopsin
  • retinoid isomerohydrolase
  • cis-trans-Isomerases
  • Retinaldehyde
Topics
  • Animals
  • Blindness (congenital, metabolism, pathology)
  • Carrier Proteins
  • Codon, Nonsense
  • Disease Models, Animal
  • Electroretinography
  • Exons (genetics)
  • Eye Proteins (genetics, metabolism)
  • Female
  • Fluorescent Antibody Technique, Indirect
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • Ophthalmoscopy
  • Phenotype
  • Photoreceptor Cells, Vertebrate (pathology)
  • Pigment Epithelium of Eye (metabolism)
  • Retinal Degeneration (genetics, metabolism, pathology)
  • Retinaldehyde (metabolism)
  • Rhodopsin (metabolism)
  • cis-trans-Isomerases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: